ABO Blood Groups, RhD Factor and Their Association with Subclinical Atherosclerosis Assessed by Carotid

Malin Mickelsson1, Kim Ekblom1,2, Kristina Stefansson1

  • 1Department of Medical Biosciences, Clinical Chemistry, Umeå University, 90187 Umeå, Sweden.

PubMed

Insights

RhD- blood group is linked to early atherosclerosis in younger adults. In older individuals with cardiovascular disease history, non-O blood groups show reduced plaque risk.

Area of Science:

  • Cardiovascular Science
  • Genetics
  • Medical Diagnostics

Background:

  • The ABO blood group system is linked to cardiovascular disease (CVD) risk, with non-O groups showing higher risk.
  • Few studies examine both ABO and RhD blood groups in relation to early atherosclerotic disease.
  • Subclinical atherosclerosis assessment in healthy populations requires further investigation regarding blood group associations.

Purpose of the Study:

  • To investigate the association between ABO and RhD blood groups and subclinical atherosclerosis.
  • To determine if blood groups influence early signs of atherosclerosis in a healthy cohort.

Main Methods:

  • Utilized data from 3532 participants in the VIPVIZA trial.
  • Assessed subclinical atherosclerosis using carotid ultrasonography.
  • Obtained blood group information from the SCANDAT-3 database.

Main Results:

  • RhD- individuals at age 40 exhibited increased carotid intima-media thickness compared to RhD+ individuals.
  • No significant ABO blood group differences were observed in the overall study population's ultrasonography results.
  • Among 60-year-olds with a family history of CVD, non-O blood groups showed reduced odds of carotid plaques.

Conclusions:

  • The RhD blood group is associated with subclinical atherosclerosis in younger individuals, suggesting a role in the atherosclerotic process.
  • A non-O blood group was linked to decreased subclinical atherosclerosis in 60-year-olds with a family history of CVD, a group with high atherosclerotic burden.